Scenarios that move NTLA
Intellia Therapeutics, Inc. - Common Stock
Scenarios that move NTLA: 3 analyses, 2 positive, 1 negative.
- · SRX Global SPV agrees to acquire CERo Therapeutics — ▲ · impact +3 · confidence low · horizon quarters
- · Spyre Therapeutics prices $350 million public stock offering — ▼ · impact -20 · confidence low · horizon immediate
- · Novartis acquires Abogen in $7.8B RNA therapeutics deal — ▲ · impact +25 · confidence low · horizon immediate